openPR Logo
Press release

New ANEROS Special Edition Products Now Available

09-07-2023 08:30 AM CET | Leisure, Entertainment, Miscellaneous

Press release from: Aneros

HOUSTON, TX - The popular sexual health and wellness innovator, Aneros, has officially launched the Prostate Health and Awareness Special Edition Blue Maximus Syn Trident and the Blue Prelude Enema Bulb Special Edition as National Prostate Cancer Awareness Month begins. These special edition items are limited-release items and only available for the month of September!

The Prostate Health and Awareness Special Edition Blue Maximus Syn Trident marks the very first release of a Maximus Syn, a new hybrid massager combining fullness and responsiveness with elegance and comfort in a specially minted blue medical grade silicone. The limited edition Prelude Enema Bulb also comes in a blue medical-grade silicone and features a unique slow-flow one-way nozzle that introduces liquid gradually and comfortably, avoiding cramping and unhygienic backflow. Both these items were specifically created to bring more attention and awareness to Prostate Cancer Awareness Month this September and help spread more information about prostate health with a focus on education, awareness, research, and support. Supplies will be limited for these Special Edition devices.

To further contribute to this wonderful cause, Aneros will be donating a portion of the proceeds from these special edition items to our long-time partner and charity ZERO® - The End of Prostate Cancer, a charity focused on prostate health, education, and resources. Aneros will also be a sponsor for the ZERO Prostate Run/Walk taking place in Houston, Texas on September 9th.

"For our 3rd Annual Aneros Goes Blue Campaign we wanted to do something special, so we are releasing our first ever Maximus Syn Trident. The concept of a Maximus Syn Trident has dominated user wish lists of Aneros products for many years now, so we are excited to be releasing it in conjunction with Prostate Cancer Awareness month and to benefit this very special cause. Available in Men's Health Edition blue, it will be offered along with the Blue Prelude Enema Bulb as limited edition items for the month of September," says Aneros Product and Business Development Manager Forrest Andrews.

Aneros is world-famous as a pioneer of handsfree prostate massage and for its original, best-selling line of sexually gratifying and "Super-O" inducing prostate massagers that also offer additional benefits for erectile dysfunction (ED), PE, and relief from prostate related health issues. Media members interested in receiving Aneros products for review and/or marketing opportunities may email Press@Aneros.com. For everything else, visit, Twitter.com/Aneros, Facebook.com/Aneros or Instagram.com/Aneros_Official.

Keywords:
Aneros, September, display, donation, charity, retail, retail contest, national prostate health month, sexual health, prostate cancer, wellness, prostate health, prostate, sexual education, prostate health issues, prostate health month, blue, health issues, risk factors, prostate massage, knowledge, education, prelude enema bulb kit, aneros prelude, new product, product release, retail, product announcement, new product announcement

Aneros
P.O. Box 55554. Houston, TX 77255
Marketing/PR:
Press@Aneros.com
Sales:
Partners@Aneros.com

Aneros is a Sexual Health and Wellness company with products focused on improving overall prostate related health issues like ED, prostatitis, BPH, inflammation, etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New ANEROS Special Edition Products Now Available here

News-ID: 3198960 • Views:

More Releases from Aneros

Aneros® Announces The Aneros Prelude™ Enema Bulb Kit
Aneros® Announces The Aneros Prelude™ Enema Bulb Kit
HOUSTON, TX (October 5, 2022) - Aneros®, the popular sexual health and wellness innovator, is excited to officially announce the release of its new Aneros Prelude™ enema bulb kit. The Aneros Prelude is a cleansing system that provides a new take on personal hygiene introducing the option of low volume internal rinsing for easier, quicker and more comfortable cleansing sessions. The Aneros Prelude features an all medical-grade velvet touch silicone
03-11-2022 | Health & Medicine
Aneros
ANEROS Makes Big Donation to Help Prostate Cancer Charity
HOUSTON, TX (March 10, 2022) - High Island High and its subsidiary, Aneros, is honored and excited to partner with Washington DC-based non-profit, ZERO: The End of Prostate Cancer, a charitable organization with a mission to end prostate cancer. Aneros donated a portion of the proceeds of the sales of a limited-edition product to ZERO in a check presentation ceremony held on Wednesday, February 16th in Los Angeles, California.

More Releases for Prostate

Prostate 911 Reviews 2021: ( Unrevealed truth) Prostate 911 100% Risk free SCAM …
Benign prostatic hyperplasia is a frequent condition that most guys have to deal with as they get older. Your prostate gland will grow to the measurement of a lemon. It will block the bladder, which will disrupt urine flow. It will motive damage to the urinary tract. It will purpose erectile dysfunction, bladder infection, and kidney problems. More than 50% of men go through from BPH between the age of
Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region. Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Prostate Cancer Therapeutics Market: Future Perspective Growth In Prostate Cance …
Global Prostate Cancer Therapeutics Market Precision Business Insights (PBI) in its report titled “Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Prostate Cancer Therapeutics Market Prostate is an exocrine
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Prostate Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Prostate Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men and
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign